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HilE Regulates HilD by Blocking DNA Binding in Salmonella
enterica Serovar Typhimurium
Jesse R. Grenz,a Jessica E. Cott Chubiz,a* Pariyamon Thaprawat,a* James M. Slaucha
aDepartment of Microbiology, University of Illinois, Urbana, Illinois, USA
ABSTRACT The Salmonella type three secretion system (T3SS), encoded in the Sal-
monella pathogenicity island 1 (SPI1) locus, mediates the invasion of the host intesti-
nal epithelium. SPI1 expression is dependent upon three AraC-like regulators: HilD,
HilC, and RtsA. These regulators act in a complex feed-forward loop to activate each
other and hilA, which encodes the activator of the T3SS structural genes. HilD has
been shown to be the major integration point of most signals known to activate the
expression of the SPI1 T3SS, acting as a switch to control induction of the system.
HilE is a negative regulator that acts upon HilD. Here we provide genetic and bio-
chemical data showing that HilE speciﬁcally binds to HilD but not to HilC or RtsA.
This protein-protein interaction blocks the ability of HilD to bind DNA as shown by
both an in vivo reporter system and an in vitro gel shift assay. HilE does not affect
HilD dimerization, nor does it control the stability of the HilD protein. We also inves-
tigated the role of HilE during the infection of mice using competition assays. Al-
though deletion of hilE does not confer a phenotype, the hilE mutation does sup-
press the invasion defect conferred by loss of FliZ, which acts as a positive signal
controlling HilD protein activity. Together, these data suggest that HilE functions to
restrict low-level HilD activity, preventing premature activation of SPI1 until positive
inputs reach a threshold required to fully induce the system.
IMPORTANCE Salmonella is a leading cause of gastrointestinal and systemic disease
throughout the world. The SPI1 T3SS is required for Salmonella to induce inﬂamma-
tory diarrhea and to gain access to underlying tissue. A complex regulatory network
controls expression of SPI1 in response to numerous physiological inputs. Most of
these signals impinge primarily on HilD translation or activity. The system is trig-
gered when HilD activity crosses a threshold that allows efﬁcient activation of its
own promoter. This threshold is set by HilE, which binds to HilD to prevent the inev-
itable minor ﬂuctuations in HilD activity from inappropriately activating the system.
The circuit also serves as a paradigm for systems that must integrate numerous en-
vironmental parameters to control regulatory output.
KEYWORDS Salmonella, SPI1, HilD, HilE
Salmonella enterica serovar Typhimurium is a Gram-negative pathogen that, wheningested, is capable of causing a range of diseases from gastroenteritis to poten-
tially lethal systemic infections in a wide range of hosts, including humans. It is a
leading cause of bacterial foodborne illness in the United States, with nontyphoid
species of Salmonella estimated to cause over 1 million infections per year (1). Salmo-
nella is deﬁned and differentiated from other Enterobacteriaceae by the presence of
Salmonella pathogenicity island 1 (SPI1). This 40-kb locus carries all of the genes
required for a functional type III secretion system (T3SS) and the regulators HilD, HilC,
and HilA (2). The additional regulators RtsA (STM14_5188) and HilE (STM14_4514) are
encoded elsewhere on the chromosome (3–5). The T3SS forms a needle-like complex
that injects bacterial effector proteins into host epithelial cells. These effectors induce
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a number of physiological responses, including inﬂammatory diarrhea and bacterial
engulfment that can lead to a systemic infection (6).
Expression of the SPI1 T3SS is controlled by a complex regulatory network (Fig. 1A).
HilA functions to activate all of the genes required to synthesize a functional T3SS
(7–10). Transcriptional activation of hilA is dependent upon three AraC-like proteins,
HilD, HilC, and RtsA, which bind to the same sites upstream of activated promoters (11,
12). Each of the three regulators activates, in addition to hilA, its own promoter as well
as those of the other two regulators, thus forming a complex feed-forward loop
(12–15).
Our data indicate that the majority of regulatory inputs into the SPI1 system are
integrated at the level of HilD (16). The overall effect is to control the ability of HilD to
activate its own promoter, the critical step in initiating expression of the SPI1 T3SS (17).
Primary examples of factors that inﬂuence HilD activity are HilE, a major negative
regulator of SPI1 T3SS expression, and the ﬂagellar gene product FliZ, which acts
indirectly upon HilD to increase activity (10, 16, 18–20). HilE and FliZ regulate the
activity of HilD simultaneously and independently (20). Our immediate goal was to
understand how HilE regulates HilD activity at the molecular level to further our
understanding of overall integration of signals into the SPI1 regulatory circuit.
Fahlen et al. identiﬁed HilE as a negative regulator of hilA transcription, and Baxter
FIG 1 (A) A simpliﬁed model for SPI1-T3SS regulation. Black lines indicate transcriptional regulation. Gray
lines indicate posttranslational regulation. For clarity, the genes encoding SPI1 regulators are not shown.
(B) HilE is a negative regulator of SPI1. Strains with hilE deleted or overexpressing hilE were grown under
SPI1-inducing conditions and analyzed via -galactosidase assay. -Galactosidase activity units are
deﬁned as (micromoles of ONP formed per minute  106)/(OD600  milliliters of cell suspension) and
reported as mean  one standard deviation (n  6, 3 sets of duplicate assays on 3 separate days). The
strains used were JS749, JS749 with pHilE, and JS2103. (C) HilE acts via HilD. The rtsA gene was under the
control of a tetA promoter, hilD was left unaltered or deleted, and HilE was overexpressed as indicated.
Strains were grown overnight under SPI1-inducing conditions and subcultured 1:100 with the indicated
concentration of anhydrotetracycline (aTc) (n 4, 3 sets of duplicate assays on 2 separate days; error bars
represent one standard deviation). The strains used were JS953 and JS2104 with pHilE or pWKS30.
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et al. provided bacterial two-hybrid data indicating that HilE directly interacts with HilD
protein (5, 21). We have also provided genetic data demonstrating that HilE operates
at the level of the HilD protein (16, 20). HilE controls an ectopically expressed HilD but
does not affect expression of hilD-lacZ transcriptional or translational fusions in the
absence of HilD (20). In this study, we provide further genetic and biochemical data
showing that HilE directly binds to HilD and blocks its ability to bind DNA but does not
affect the dimerization or stability of HilD. Consistent with our previous genetic data,
HilE is speciﬁc for HilD and does not bind or affect HilC or RtsA. In vivo data suggest that
during infection, FliZ acts to overcome the negative regulation of HilE to switch on SPI1
T3SS expression in the intestine.
RESULTS
HilE acts speciﬁcally upon HilD. Previous data suggest that HilE acts directly at the
level of the HilD protein (5, 16, 20, 21). We sought to further understand the molecular
mechanism by which HilE controls HilD protein activity. Figure 1B shows the effect of
HilE on hilA expression. In the absence of HilE, hilA transcription was increased 4-fold,
whereas overproduction of HilE decreased hilA transcription by 50-fold, consistent
with previous data (20, 21). Our previous results showed that HilE does not regulate
HilC or RtsA activity in the absence of HilD (16). To conﬁrm this ﬁnding, we constructed
a strain in which rtsA is placed under the control of the tetRA cassette. Otherwise
isogenic variations of this strain included the deletion of hilD and/or overexpression of
HilE, which should maximize any effect. Upon induction with anhydrotetracycline under
SPI1-inducing conditions, we observed the effect of HilE only in the HilD-producing
strain (Fig. 1C). Because these strains express both RtsA and HilC, we can conclude that
HilE acts only through HilD, consistent with our previous experiments examining the
effects of a hilE deletion (16).
HilE binds directly and speciﬁcally with HilD. To characterize the interaction
between HilE and HilD, we ﬁrst conﬁrmed the results of Baxter et al. (21) using a
bacterial two-hybrid system. In this system, IPTG (isopropyl--D-thiogalactopyranoside)
induces the expression of a LexA DNA binding domain (LexADBD) fused to the C
terminus of a protein of interest. If the protein of interest dimerizes, the LexADBD binds
to its cognate sulA promoter, repressing the expression of a transcriptionally linked lacZ
gene. Alternatively, a mutant LexADBD and a half-mutant sulA promoter can be used to
test for heterodimerization of two proteins (21–23). We created hilD-lexADBD and
hilE-lexADBD constructs. The data in Fig. 2A suggest that ﬁrst, HilD forms homodimers,
and second, HilE and HilD indeed interact via protein-protein interaction.
To verify these data and to determine if HilE is capable of interacting with either HilC
or RtsA, we performed a coimmunoprecipitation assay using strains containing FLAG-
tagged HilE and Myc-tagged HilD, HilC, or RtsA constructs. HilE was immunoprecipi-
tated using anti-FLAG antibodies, and the coprecipitation of HilD, HilC, or RtsA was
monitored via Western analysis. The data in Fig. 2B indicate that HilE speciﬁcally binds
HilD but not HilC or RtsA in vivo. Both the two-hybrid and coimmunoprecipitation data
are consistent with our genetic model (Fig. 1A) and previous data indicating that HilE
controls HilD protein activity but does not affect either HilC or RtsA (16).
HilE speciﬁcally disrupts HilD DNA binding activity. One can envision several
ways in which HilE could mechanistically regulate the activity of HilD. (i) HilE may simply
interact with HilD in such a way that it blocks DNA binding. (ii) Given the results above
and our unpublished data indicating that HilD forms homodimers in vivo, it is possible
that HilE disrupts HilD dimerization and thereby indirectly blocks HilD DNA binding and
activation of the hilA promoter. (iii) HilD has been reported to be degraded by Lon
protease (24, 25). HilE could bind HilD and deliver it to Lon or another protease. (iv) HilE
could regulate HilD function after HilD has bound to DNA. However, HilD functions
partially by displacing H-NS (11), making the last model more difﬁcult to imagine.
We ﬁrst examined the ability of HilE to block HilD DNA binding. To provide a direct
in vivo assay of HilD DNA binding, we created an artiﬁcial promoter that includes an
overlapping HilD/HilC binding site and which drives the expression of lacZ, analogous
HilE Blocks HilD DNA Binding Journal of Bacteriology
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to the method used by Luo and Farrand (26). In this construct, HilD or HilC should act
as a simple repressor, occluding the binding of RNA polymerase. Thus, HilD and HilC
DNA binding could be analyzed independent of displacement of H-NS or activation of
RNA polymerase. We placed HilD or HilC under tetRA control in strains containing the
synthetic promoter construct and in which the chromosomal hilD, hilC, rtsA, and hilE
loci were deleted. These strains were grown in low-salt LB (LSLB) medium with various
concentrations of tetracycline. When induced with tetracycline, there was marked a
decrease in -galactosidase activity in both the HilD- and HilC-producing strains (Fig. 3).
These data suggest that both HilD and HilC act as simple repressors when bound to this
synthetic promoter.
To determine if HilE prevents HilD from DNA binding, we introduced a plasmid
encoding HilE into the above-mentioned strains. As shown in Fig. 3, HilE blocked the
reduction in -galactosidase activity in the HilD-producing strain but had no effect in
the HilC-producing background. We interpret these data to indicate that HilE prevents
HilD from binding DNA but does not affect HilC. This is consistent with our model (Fig.
1A) and with previous genetic data (14, 16, 20).
We next sought to biochemically verify these results. For these experiments, we
used small ubiquitin-related modiﬁer (SUMO)-tagged HilD and HilC. These SUMO-
tagged constructs are functional in vivo and in vitro (see Fig. S1 in the supplemental
material) and are more soluble than untagged proteins. We also puriﬁed HilE as a
SUMO-tagged protein but then proteolytically removed the SUMO tag. We mixed either
SUMO-tagged HilD or HilC with a fragment of the hilA promoter region and tested
whether the addition of HilE would disrupt any shift of the DNA. As shown in Fig. 4,
both HilD and HilC shifted a fragment of the hilA promoter, consistent with previous
ﬁndings (11). Addition of HilE blocked DNA binding by HilD but had no effect on the
HilC-mediated gel shift. Combined with our ﬁndings from Fig. 3, we interpret these data
to indicate that HilE prevents HilD from binding DNA but does not affect HilC.
HilE does not affect HilD dimerization. HilE could block HilD DNA binding
indirectly by preventing HilD dimerization. To test whether HilD dimerization was
FIG 2 HilE speciﬁcally interacts with HilD. (A) A bacterial two-hybrid system with the indicated genes
fused to either a wild-type or mutant lexA DNA binding domain were grown overnight in LSLB medium
at 37°C and then subcultured 1:100 and allowed to incubate at 37°C for 18 h in LSLB medium containing
the indicated concentration of IPTG. The genes fos and jun were employed as a positive control (n  6,
3 sets of duplicate assays on 3 separate days; error bars represent one standard deviation). The strains
used were SU202 with either pMS604 and pDP804, pSR659::hilD, pSR659::hilD and pSR658::hilE, or
pSR659::hilD and pSR658::hilD. (B) Strains containing FLAG-tagged HilE and Myc-tagged HilD, HilC, or
RtsA were grown overnight and lysed with a French pressure cell. Whole-cell extract (WCE) was then
analyzed via Western blotting using either anti-FLAG or anti-Myc antibodies. Extracts were immunopre-
cipitated using anti-FLAG magnetic beads and subsequently analyzed via Western blotting using
anti-Myc. The strains used were 14028 with pLS118, pLS119, or pCE81 and JS2105 with pLS118, pLS119,
or pCE81.
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affected, we employed the bacterial two-hybrid system (22, 23). The data in Fig. 5
suggest that both HilD and HilC homodimerize, as evidenced by an IPTG-dependent
decrease in -galactosidase activity. The addition of HilE to this system did not
markedly alter the ability of the HilD- or HilC-LexADBD proteins to repress lacZ expres-
sion. Although not conclusive, these data suggested that HilE does not disrupt HilD or
HilC homodimerization.
To further test whether HilE affects HilD dimerization, we ﬂuorescently labeled either
SUMO-tagged HilD or HilC and mixed the labeled protein in a 5% molar ratio with
unlabeled SUMO-tagged HilD or HilC. These samples, with or without the addition of
puriﬁed HilE, were separated via size exclusion chromatography over a Superose 12
HR 10/30 column, and the ﬂuorescence of each fraction was measured. The use of
ﬂuorescently labeled protein allowed us to speciﬁcally monitor the elution of HilD or
HilC but not HilE, which is unlabeled. The molecular masses of monomers and dimers
of SUMO-HilD should be 47.7 kDa and 95.4 kDa, respectively; SUMO-HilC monomers
and dimers should be 46.4 kDa and 92.7 kDa, respectively. In Fig. 6, we observe that
both HilD and HilC eluted from the column consistent with the predicted mass of
SUMO-tagged dimers. Structural prediction suggests that HilE should be a hexamer
with a total molecular mass of 100 kDa. The addition of HilE in the HilD sample led to
formation of a ﬂuorescent species that eluted with an apparent molecular mass that
FIG 3 HilE selectively blocks HilD DNA binding. (A) Sequence of the pJG1 HilD/HilC DNA binding reporter
plasmid. Bases important for HilD/HilC binding are indicated by underlining (11). The recognition
sequences for the restriction enzymes used in the creation of pJG1, the 35 and 10 promoter
sequences, the predicted start site of transcription, and the start of the lacZ open reading frame are
indicated. (B) Strains contained a HilD/HilC-repressible lac fusion and hilD or hilC under the control of a
tetA promoter. Where indicated, HilE was overexpressed. Strains were incubated overnight at 37°C in
LSLB medium with various concentrations of tetracycline (n  6, 3 sets of duplicate assays on 3 separate
days; error bars represent one standard deviation). The strains used were JS2106 and JS2107 with or
without pHilE.
FIG 4 HilE selectively blocks HilD DNA binding. The samples contained 0.7 M puriﬁed HilD or HilC, 0.56
M DNA, and, where indicated, 2.25 M HilE. Samples were electrophoresed on a 10% continuous
polyacrylamide gel and subsequently stained with SYBR Safe.
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was signiﬁcantly greater than 180 kDa. The addition of HilE to the SUMO-tagged HilC
sample had no effect on elution. This is consistent with a predicted protein complex
composed of 2 HilD and 12 HilE monomers (295 kDa). The alternative model is that a
hexamer of HilE would be bound to a HilD monomer, giving a predicted mass of 148
kDa. Combined, these data show that HilE binds to HilD without disrupting the HilD
dimer. Further studies are required to determine the actual stoichiometry of the
complex.
HilD remains stable in the presence of HilE. We next determined whether HilE
regulates HilD activity via modulating its stability. To avoid the complication of HilD
autoactivation, we constructed strains in which the expression of a HilD-3FLAG is
under the control of tetRA. Furthermore, these strains contained a hilA=-lacZ construct,
allowing us to measure HilD activity. We constructed hilE, ΔhilE, and pHilE variations
of these strains. It has been reported that HilD, HilC, and RtsA are degraded by Lon
protease (24, 25). We therefore created otherwise isogenic Δlon Δwca variations of the
above-mentioned strains. (The Δwca blocks capsule production, a complicating phe-
notype of Δlon strains.) All strains were grown overnight and subcultured for 2.5 h with
tetracycline at a concentration that leads to activation of hilA to approximately wild-
type levels. After incubation, an aliquot was withdrawn to determine hilA promoter
activity via -galactosidase assay. The remaining cells were immediately boiled in
sodium dodecyl sulfate (SDS) loading buffer. The proteins in each aliquot were then
resolved via SDS-PAGE and visualized using anti-FLAG antibody. As shown in Fig. 7, we
FIG 5 HilE does not disrupt HilD dimerization. A bacterial monohybrid system with the indicated genes
fused to a wild-type lexA DNA binding domain were grown under SPI1-inducing conditions with the
indicated concentrations of IPTG. Where indicated, hilE was overexpressed from pWKS30 (n  6, 3 sets
of duplicate assays on 3 separate days; error bars represent one standard deviation). The strains used
were SU101 with pSR658, pDD506, pSR658::hilD, or pSR658::hilC with and without pHilE.
FIG 6 HilE does not disrupt HilD dimerization. Puriﬁed SUMO-HilD or SUMO-HilC was ﬂuorescently
labeled and mixed in a 1:20 molar ratio with unlabeled SUMO-HilD or SUMO-HilC. Unlabeled HilE was
mixed in a 12:1 molar ratio with either HilD or HilC where indicated. Proteins were separated by size
exclusion chromatography, and the ﬂuorescence of each fraction was assayed. The elution fraction and
molecular mass of protein standards are labeled.
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observed HilE-dependent hilA promoter activity consistent with our genetic model and
with previous ﬁndings (20). The effect of deleting hilE is dampened in these back-
grounds, likely due to the lack of HilD autoregulation. Importantly, overproduction of
HilE completely blocked hilA expression. However, the steady-state levels of HilD-
3FLAG were only slightly different in the various backgrounds. Although HilD activity
was slightly increased in the Δlon background, overproduction of HilE blocks this
activity without having any signiﬁcant effect on the steady-state levels of the protein.
These results suggest that HilE binds and directly blocks HilD function and that
degradation of HilD is not a signiﬁcant mechanism of regulation.
A hilE mutation partially suppresses the invasion defect conferred by loss of
FliZ. HilE is a major negative regulator of HilD and therefore of SPI1 T3SS expression.
We therefore wished to determine whether HilE-mediated regulation is important
during intestinal invasion. To test this, we performed oral and intraperitoneal (i.p.)
competition assays, infecting BALB/c mice with a 1:1 mixture of ΔhilE and wild-type
strains and, after 2.5 days, determining the ratio of the two strains in the small intestine
and the spleen. As shown in Table 1, the ΔhilE strain conferred no signiﬁcant phenotype
in either oral or i.p. competition assays. This is perhaps not surprising, given that
the negative regulatory effects of HilE must be normally overcome during intestinal
infection.
It has been previously shown that FliZ signiﬁcantly affects SPI1 T3SS regulation both
in vivo and in vitro, with a ΔﬂiZ strain conferring an12.5-fold SPI1-dependent invasion
phenotype (20). HilE and FliZ act both independently and simultaneously to regulate
HilD (16, 20). We therefore asked whether a ΔhilE mutation would suppress a ΔﬂiZ
phenotype. We performed both oral and i.p. competition assays using a 1:1 mixture of
ΔhilE ΔﬂiZ and ΔﬂiZ strains. After 3 days, we measured the ratio of the strains in the
spleen and small intestine. As shown in Table 1, the ΔhilE ΔﬂiZ strain was 5-fold more
FIG 7 HilE regulates HilD activity independently of stability. The hilD-3XFLAG construct is expressed from
a tetA promoter. Strains with the indicated genotypes were grown to mid-log phase and induced with
tetracycline. Western blotting and -galactosidase assay were performed using aliquots from the same
sample. Densitometry of the Western blot was performed using ImageJ. HilD levels and -galactosidase
activity were normalized to those of the hilE strain. The strains used were JS2108, JS2109, JS2110,
JS2111, JS2112, and JS2113.










A B Median CIb Pc Median CI P
ΔhilE WT i.p. 103 5 1.41 NS 0.79 NS
Oral 107 5 0.66 NS 0.93 NS
108 15 2.08 NS 1.41 NS
ΔhilE ΔﬂiZ ΔﬂiZ i.p. 103 9 0.92 NS 0.85 NS
Oral 107 9 3.35 0.01 1.88 0.04
108 5 4.97 0.01 4.21 0.06
aThe strains used were JS135, JS996, JS2115, and JS2116.
bThe competitive index (CI) was calculated as described in Materials and Methods.
cThe Student t test was used to compare the CIs to those for the inocula. NS, not signiﬁcant.
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invasive than the ΔﬂiZ strain. In all cases, no phenotype was observed after i.p.
infection, indicating that the differences in infectivity between the strains were due to
differences in invasiveness alone and not survivability within the animal. These data
suggest that the deletion of hilE is capable of partially rescuing the invasion deﬁcit
conferred by ΔﬂiZ.
DISCUSSION
Salmonella enterica has evolved a complex regulatory network to control the
expression of the SPI1 T3SS, which is central to the ability of Salmonella to cause
gastroenteritis and invade the intestinal epithelium. We have developed a model for
the SPI1 regulatory network and have begun to understand the mechanisms by which
a large number of signals impinge upon this regulatory system (14, 16). In this work, we
focused on HilE, a major negative regulator of HilD with a central role in SPI1 regulation.
HilE was previously identiﬁed as a negative regulator of the SPI1 T3SS, and two-
hybrid data suggested that HilE binds directly to HilD (5, 21). We previously provided
genetic evidence that the HilE regulatory effect is mediated through HilD (16, 20). Here
we provide genetic and biochemical data showing that HilE directly binds to HilD and
blocks its ability to bind DNA. These studies included the use of a synthetic promoter
in which a HilD/HilC binding site is integrated into the 10 and 35 sequences,
resulting in a promoter that is repressible by HilD and HilC, allowing us to study HilD
and HilC DNA binding in vivo, independent of any interactions with H-NS or RNA
polymerase. HilE does not block dimerization, nor does it signiﬁcantly affect the stability
of HilD. This regulation by direct protein-protein interaction explains the phenotype
conferred by both hilE null and HilE overproduction, which completely blocks HilD
activity.
Accumulated data suggest that HilD acts as the integration point for many of the
environmental signals that control SPI1 expression. HilC and RtsA act as ampliﬁers of
these signals. Although the actual mechanism is known in only a few cases, we have
shown that regulation is primarily through either translation of the hilD message or
control of HilD protein activity (14, 16, 19, 27). HilE falls into the latter class. Saini et al.
demonstrated that the interaction of HilD with the hilD promoter is the trigger for
inducing the expression of SPI1 through a stepwise increase of hilD promoter activity
and autoactivation (17). Thus, the system is switched on when HilD activity reaches
some threshold sufﬁcient to efﬁciently activate its own expression. It is the amount of
HilE that sets this threshold, by blocking the activity of low levels of HilD and thus
preventing the inevitable minor ﬂuctuations in HilD activity (noise) from inappropri-
ately activating the system.
The N-terminal domains of HilD, HilC, and RtsA share approximately 10% identity,
whereas the C-terminal DNA binding domains share 46% identity. The three proteins
bind to the same DNA sequences to activate transcription of the hilD, hilC, rtsA, and hilA
genes (11, 12, 15). Despite this homology, HilE functions solely through HilD. HilE does
not interact with HilC or RtsA, nor does it have any regulatory effect in the absence of
HilD. Our unpublished data suggest that HilD, HilC, and RtsA form both homodimers
and heterodimers. HilE does not apparently affect dimerization. We propose that HilE
binds independently to the individual HilD proteins in both homodimers and het-
erodimers containing HilD. This would allow HilE to efﬁciently block induction. Other-
wise, heterodimers containing HilD would be capable of inappropriately activating
expression of the SPI1 system.
How the level of HilE and, thus, the threshold of activation is controlled is only
partially understood. Expression of hilE is apparently activated primarily by FimZ, but
this regulation is modest under normal conditions. Loss of FimZ results in less than a
2-fold increase in hilA expression and a slight delay in the timing of SPI1 turning off in
an in vitro experiment (17, 28). Only when FimZ is artiﬁcially overexpressed is there a
dramatic effect on SPI1 expression (17, 28). Mlc is a transcriptional repressor considered
a global regulator of carbohydrate metabolism (29–31). Lim et al. showed that loss of
Mlc leads to a 2-fold increase in hilE mRNA levels and a 4-fold HilE-dependent decrease
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in invasion (32). They provide evidence that Mlc acts directly in the hilE promoter
region, but the effects of various carbon sources on SPI1 expression and the physio-
logical relevance are not clear. The transcriptional regulator LeuO is normally repressed
by H-NS under laboratory conditions. Ectopic expression of LeuO in Salmonella tran-
scriptionally induces hilE and leads to decreased expression of all of the SPI1 regulators.
However, importantly, production of LeuO decreases hilD transcription in the absence
of HilD, decreases hilC and rtsA transcription in the absence of both HilD and HilE, and
leads to an invasion defect in the absence of HilE (33). Thus, although there is an
apparent effect on hilE transcription, the predominant regulatory effects on SPI1 are
HilE independent and seem to be global, analogous to the effects of H-NS (16). The
PhoPQ two-component system strongly represses SPI1 gene expression (16). Baxter and
Jones recently reported that PhoP activates hilE transcription in a manner that is
somehow dependent on FimZ (34). However, our data show that PhoPQ can repress the
system independently of HilD and HilE (reference 6 and unpublished data); thus, this
transcriptional induction of hilE is apparently superﬂuous. Baxter and Jones also report
that deletion of pstS, which induces the PhoBR two-component system, leads to
transcriptional induction of ﬁmZ and hilE and decreased expression of hilA (34).
Understanding the overall impact of PhoBR in the SPI1 system will require further
investigation.
Wang et al. provided evidence that the small RNA InvS (STnc470) negatively affects
FimZ levels by an undeﬁned mechanism (35). Deletion of invS leads to increased levels
of FimZ, which should lead to increased expression of hilE (not tested). However,
deletion of invS did not affect transcription of HilD-dependent invF, as would be
expected if the phenotype were mediated through HilE. Rather, secretion, but not
production, of effector proteins was reduced in an invS deletion strain, reportedly via
control of translation of prgH, encoding a component of secretion machinery. The small
RNA IsrM is reported to directly block translation of hilE by base pairing at the initiation
codon (36). Deletion of isrM decreased SPI1 gene expression, although transcriptional
effects were never quantiﬁed. However, the isrM deletion mutant is signiﬁcantly
attenuated in an animal, apparently during systemic stages of the disease, in which SPI1
is neither expressed nor required. These data suggest that IsrM has pleiotropic effects,
and further studies are required to determine the relative role of hilE translation in
these phenotypes. Together, these data suggest that although there is some regulation
of hilE transcription and translation, this regulation is not dramatic under normal
conditions and/or the identiﬁed regulators have effects on the system that are inde-
pendent of HilE. We believe that a low-level regulation is consistent with the primary
role of HilE in setting the threshold for activation rather than being a primary mech-
anism to repress the system in response to particular environmental signals.
Competition assays between ΔhilE and wild-type strains indicated no signiﬁcant
phenotype as a result of the loss of HilE (Table 1). This observation is consistent with
previously published data indicating that the deletion of hilE confers no invasion
phenotype in HEp-2 cells (28). It has been previously demonstrated that the deletion
of ﬂiZ, encoding a strong positive regulator of HilD, causes a defect in the ability of
Salmonella to invade the host intestinal epithelium (20). However, deletion of hilE in a
ΔﬂiZ background led to a 3- to 5-fold increase of the competitive index (CI) over a ΔﬂiZ
background. These data together suggest that the negative regulatory effects that HilE
has upon HilD are overcome by the point at which Salmonella reaches the small
intestine and the site of invasion, consistent with the overall role of HilE in setting the
threshold of activation that is overcome at the appropriate time and place during
infection.
It has been suggested that Lon protease regulates SPI1 expression by the degra-
dation of SPI1 regulatory components (24, 25), and HilD stability has been invoked
numerous times to help explain regulatory effects (37–41). We previously demon-
strated, however, that loss of Lon causes increased SPI1 expression by stabilizing FliZ
and not the SPI1 regulatory components per se (20). We did note a change in the
steady-state levels of HilD in response to HilE. The half-life of HilD-FLAG has been
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reported to be from 40 to 155 min by various investigators (20, 37, 38, 40, 41). Under
our conditions, the HilD half-life changed from 75 min in a wild-type background to
40 min when HilE was overproduced (data not shown). However, the effect of HilE
upon HilD activity does not correlate with the relative levels of HilD; overexpression of
HilE resulted in a 50-fold decrease in hilA expression, while there was only 10% less HilD
protein at the time that activity was measured (Fig. 7). This shows that the primary
effect of HilE is to directly regulate HilD DNA binding activity and that any effect on HilD
stability is a secondary effect. We propose that the changes in HilD half-life conferred
by changing HilE levels are a result of HilD being slightly more unstable when free in
solution than its DNA-bound form. This likely contributes to the effects seen for other
regulatory inputs. Proteins that are truly regulated by modulating stability, such as
RpoS, RpoH, and SulA, have half-lives on the order of 1 to 2 min under the unstable
condition and are stabilized to 30 min in the induced state (42). In those cases where
the stability of HilD has been invoked in regulation, the measured half-life under the
“unstable” condition remained 15 min. It is difﬁcult to imagine that these purported
2- to 3-fold changes in half-life in what is a relatively stable protein constitute the
primary mechanism of regulation. It seems more likely that these various factors have
some more direct effect on HilD activity.
Overall, our data suggest that the role of HilE is to simply bind to HilD, disrupting
its ability to bind to DNA, thereby putting HilD into an inactive or low-activity state. The
ability of HilE to maintain HilD in such a state is then overcome by the positive
regulatory effects, including FliZ, at the time when Salmonella reaches the site of
invasion in the small intestine. At this point, HilD is able to autoactivate its own
promoter, as well as those of HilC and RtsA, leading to robust and rapid induction of
the SPI1 T3SS.
MATERIALS AND METHODS
Construction of strains and plasmids. All Salmonella strains are isogenic derivatives of Salmonella
enterica serovar Typhimurium strain 14028 (American Type Culture Collection) and are listed in Table S1
in the supplemental material. Gene deletions and concomitant insertion of an antibiotic resistance
cassette were constructed using  Red-mediated recombination as previously described (43, 44). All
constructs were veriﬁed by PCR and moved into a clean background via P22HTint105 phage transduction
(45). In some cases, the antibiotic resistance cassette was removed by FLP-mediated recombination via
the introduction of pCP20 (46).
Media, reagents, and enzymatic assays. Strains were routinely grown using high-salt lysogeny
broth (HSLB) (0.5% yeast extract, 1% tryptone, 1% NaCl) medium (47) at 37°C, except for strains
containing the temperature-sensitive plasmid pKD46, pInt, or pCP20, which were grown at 30°C. Where
indicated, strains grown under Salmonella pathogenicity island 1 (SPI1)-inducing conditions were cul-
tured overnight in 3 ml low-salt LB (LSLB) medium (0.5% NaCl) in 13-mm culture tubes at 37°C on a rotary
drum and then subcultured 1:100 and grown in 3 ml HSLB medium in standing cultures (low oxygen) in
13-mm tubes at 37°C for 12 to 16 h. For non-SPI1-inducing conditions, cells were grown in LSLB medium
at 37°C in a rotary drum for 12 to 16 h. Antibiotics were used at the following concentrations: ampicillin,
25 or 50 g/ml; chloramphenicol, 20 g/ml; kanamycin, 50 g/ml; apramycin, 50 g/ml; and tetracycline,
13 g/ml. Antibodies were purchased from Sigma (monoclonal anti-FLAG M2 and monoclonal anti-c-
Myc) or R&D Systems (rabbit anti-mouse IgG conjugated to horseradish peroxidase). Enzymes were
purchased from Invitrogen, New England BioLabs, or Stratagene and used according to the manufac-
turers’ recommendations. Primers were obtained from IDT.
-Galactosidase assays were performed using a 96-well microtiter plate assay as previously described
(48). Unless otherwise indicated, cells were grown under SPI1-inducing conditions for these assays. The
indicated amount of anhydrotetracycline (aTc) or isopropyl--D-thiogalactopyranoside (IPTG) was added
for speciﬁc gene induction. -Galactosidase activity units are deﬁned as (micromoles of ortho-
nitrophenol [ONP] formed per minute  106)/(optical density at 600 nm [OD600]  milliliters of cell
suspension) and are reported as mean  one standard deviation.
Coimmunoprecipitation. We constructed strains containing Myc-tagged HilD, HilC, or RtsA on a
plasmid and a FLAG (SPA)-tagged HilE inserted into the chromosome. These strains were grown
overnight and subsequently harvested by centrifugation and then lysed in a French pressure cell. The
protein concentration was determined by bicinchoninic acid (BCA) assay (Pierce). Anti-Myc magnetic
beads (Pierce/Thermo Fisher) were washed twice in Tris-buffered saline (TBS) with Tween (TBST) (25 mM
Tris, 150 mM NaCl, 0.05% Tween 20) after being collected in a magnetic stand. Whole-cell extracts (WCE)
containing 100 g of protein were mixed with a 4-fold excess of TBST and magnetic beads and then
allowed to incubate for 30 min while mixing via rotation. The beads were then collected using a
magnetic stand and washed twice in 5 TBST. Bound protein was then eluted from the magnetic beads
using SDS-PAGE sample buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 1% -mercaptoethanol,
12.5 mM EDTA, 0.02% bromphenol blue) and heating the samples to 95°C for 15 min before analysis via
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Western blotting. The samples were separated on a 10% discontinuous SDS-polyacrylamide gel and
transferred to Hybond ECL membranes (Amersham). The membranes were blocked three times for 10
min each using 5% (wt/vol) nonfat dry milk in Tris-buffered saline (TBS) (5% milk, 50 mM Tris, 150 mM
NaCl, pH 8.0). The blots were then exposed to anti-FLAG M2 or anti-c-Myc antibody diluted 1:1,000 in
TBS–5% milk overnight at 4°C. The blots were washed three times for 10 min each time in TBS–5% milk
and then exposed to rabbit polyclonal anti-mouse IgG conjugated to horseradish peroxidase (R&D
Systems) diluted 1:1,000 in TBS–5% milk for 1 h. The blots were then washed in Tris-buffered saline (TBS)
(50 mM Tris, 150 mM NaCl, pH 8.0) three times for 5 min each repetition. The membranes were then
exposed to Amersham ECL Western blot detection reagents (GE Healthcare) for 1 min and exposed to
ﬁlm (Kodak).
HilD/HilC DNA binding reporter. To build a construct in which HilD or HilC acts as a simple
transcriptional repressor, we synthesized four pairs of complementary oligonucleotides. Each pair
consisted of a consensus promoter into which a HilD/HilC binding sequence had been integrated at
various positions relative to the 10 and 35 promoter sequences. These fragments were cloned into
pDX1 upstream of the promoterless lacZ gene between the unique KpnI and EcoRI sites (10). After
passage through the Salmonella strain JS198 (r m), the plasmids were transformed and stably
integrated in single copy at att by Int-mediated recombination (49), thus creating single-copy tran-
scriptional fusions of the synthetic promoter and lacZ. The resulting constructs were veriﬁed to have a
single integrated copy of the plasmid by PCR. These lacZ fusions were then moved via P22 transduction
into ΔhilE ΔrtsA ΔSPI1 strains containing either tetracycline-inducible hilD or hilC. The resulting colonies
were then screened by -galactosidase assay to determine the extent to which HilD or HilC was able to
repress expression from the synthetic promoter. The strain with the greatest repression upon tetracycline
induction was selected for further studies.
To further increase the responsiveness of the strain to the induction of HilD or HilC, we mutagenized
the 35 region of the synthetic promoter via PCR mutagenesis and reconstructed the fusion strains as
described above. The resulting mutants were screened on medium containing tetracycline and X-Gal
(5-bromo-4-chloro-3-indolyl--D-galactopyranoside). Colonies demonstrating a robust reduction of
-galactosidase activity on X-Gal were selected and analyzed further. The colony with the most robust
decrease of -galactosidase activity upon induction with tetracycline was then selected, and the DNA
sequence was determined. Final isogenic strains were then grown overnight in HSLB medium with 0,
0.78, 1.56, or 3.13 mg/ml tetracycline and analyzed via -galactosidase assay.
Protein puriﬁcation and gel ﬁltration. Translational fusions of hilD, hilC, or hilE to the small
ubiquitin-related modiﬁer (SUMO) were constructed using the pET-SUMO plasmid (Invitrogen; the
SUMO-HilD construct was a gift from Marc Erhardt). These constructs were then transformed into
Escherichia coli BL21(DE3) (50). These expression strains were grown overnight and subsequently
subcultured 1:100 and incubated for 4 h at 37°C. At this point, 1 mM IPTG was added for induction, and
the cells were incubated overnight at room temperature. The cells were then pelleted by centrifugation
at 7,000 g for 10 min and resuspended in NPI buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole)
with a protease inhibitor cocktail (Roche). The cells were lysed with a French press and the lysate clariﬁed
by centrifugation at 22,000 g for 1 h. The proteins were isolated by passing the clariﬁed cell lysate over
Ni-nitrilotriacetic acid (Ni-NTA)–agarose columns (Qiagen), washed with NPI buffer containing 90 mM
imidazole, and eluted from the columns using NPI buffer with 250 mM imidazole. The proteins were
concentrated by the use of centrifugal concentrators (Amicon). The protein was further puriﬁed via size
exclusion chromatography over a Superose 12 HR 10/30 column and reconcentrated via centrifugal
concentrators (Amicon) before use. The protein concentration was determined by the BCA assay (Pierce).
HilE was cleaved from the SUMO tag using SUMO protease (Invitrogen) and the protease and cleaved
SUMO tag removed from the solution by passage over an Ni-NTA column (Qiagen). The HilE was
subsequently reconcentrated with a centrifugal concentrator and further puriﬁed by size exclusion
chromatography. The protein elutes as a series of overlapping peaks, consistent with structural predic-
tions of multimerization to a hexamer (see Fig. S2 in the supplemental material). The Superose 12 HR
10/30 column used for both puriﬁcation and size exclusion chromatography of the HilD-HilE complex has
a resolution 1 to 300 kDa and an exclusion limit of 2,000 kDa.
Electromobility shift assay. HilD, HilC, and HilE were puriﬁed as described above. The hilA promoter
region is a known target of both HilD and HilC binding (11). Part of the hilA promoter (corresponding to
base pairs 3033211 to 3033421, inclusive; NCBI genome accession number CP001363.1) was ampliﬁed via
PCR and puriﬁed using a DNA spin column (Qiagen). Puriﬁed HilD or HilC was mixed with DNA in protein
binding buffer (20 mM HEPES, 20 mM KCl, 1% glycerol, 50 M EDTA) to establish a solution of 1 M HilD
or HilC and 15 nM DNA. HilE was added as indicated to a ﬁnal concentration of 3 M. A continuous 10%
polyacrylamide gel was prerun for 30 min before loading the samples. The gel was then stained with
SYBR Safe DNA gel stain (Invitrogen) and the image obtained on a transilluminator (Bio-Rad).
Bacterial mono- and two-hybrid methods. Translational fusions of hilD, hilC, or hilE to the LexA
DNA binding domain were constructed in pSR659 and pSR659 (23). These constructs were then
transformed into either the SU101 (homodimer) or SU202 (heterodimer) E. coli strain containing a
LexA-repressible sulA promoter that drives the expression of lacZ. These strains were grown overnight in
3 ml HSLB medium at 37°C and then subcultured 1:100 and grown for 18 h at 37°C in 3 ml HSLB medium
containing 0, 5, 10, or 25 M IPTG. A plasmid producing only the LexA DNA binding domain (pSR658)
or a Cat-LexADBD fusion served as a negative or positive control for the bacterial monohybrid system
(SU101), respectively (22). Plasmids pSR658 and pSR659 encoding only the DNA binding domains or
encoding fos and jun were used as negative and positive controls for the two-hybrid (SU202) system,
respectively. The strains were then analyzed via -galactosidase assay as described above.
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Stability assay methods. To measure HilD protein stability, we cultured a tetRA-hilD-3FLAG
att::pDX1::hilA=-lacZ strain in 3 ml LSLB medium in 13-mm culture tubes overnight at 37°C on a rotary
drum. The cells were subcultured 1:100 in 10 ml HSLB medium containing 0.8 g/ml tetracycline in
18-mm culture tubes and grown in a rotary drum for 2.5 h at 37°C. After 2.5 h, the OD600 of each sample
was measured and the volume adjusted with HSLB medium to equalize the concentration of cells. One
milliliter of each sample was then withdrawn for -galactosidase assays as described above. Additional
one-milliliter aliquots were removed from each culture and immediately centrifuged for 1 min at
14,000  g. The pellets were resuspended in 120 l sodium dodecyl sulfate (SDS) loading buffer (50 mM
Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 1% -mercaptoethanol, 12.5 mM EDTA, 0.02% bromphenol blue)
and boiled for 10 min before being analyzed via Western blotting as described above using anti-FLAG
antibodies. Densitometry of the resulting blots was performed using NIH ImageJ, and protein levels were
determined by measuring the area under the curve for the resulting protein bands.
Virulence assays. We inoculated 6- to 8-week-old BALB/c mice (Envigo) via oral gavage or intra-
peritoneal (i.p.) injection with 0.2 ml of bacterial cell suspension. In all the competition assays, the
inoculum consisted of a 1:1 mixture of two bacterial strains. The actual CFU and relative percentage of
each strain were determined by direct plating of the inocula. Cells were cultured overnight in HSLB
medium in 13-mm tubes at 37°C in a rotary drum. For oral infections, the cells were washed in sterile 0.1
M phosphate-buffered saline (PBS) (pH 8.0) and suspended at 5  107 or 5  108 cells/ml. For i.p.
infections, the cells were washed in sterile saline and diluted to 5  103 cells/ml in 0.15 M NaCl. Food
was withdrawn 4 h prior to oral infection. Food and water were provided ad libitum after infection. The
mice were sacriﬁced via CO2 asphyxiation 2.5 days after infection, and the small intestines and spleens
were harvested. The organs were homogenized, and aliquots of serial dilutions were plated to appro-
priate selective medium to determine the number of CFU per organ. The ratio of the two strains was
determined by replica plating to appropriate antibiotic-containing medium. The competitive index (CI)
was calculated as (CFU of strain A recovered/CFU of strain B recovered)/(CFU of strain A inoculated/CFU
of strain B inoculated). Each mutant strain was reconstructed at least once to verify that the observed
phenotypes were a result of the designated mutation. The Student t test was used to determine whether
the output ratio was signiﬁcantly different from the input ratio. All animal work was reviewed and
approved by the University of Illinois Institutional Animal Care and Use Committee and performed under
protocols 10050 and 13030.
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